Answers are grounded in this paper and cite their sources.
Our centre, the Dutch spontaneous reporting system for adverse drug reactions, recently received five reports of thromboembolism as a suspected adverse drug reaction to the new oral contraceptive Yasmin (ethinylestradiol and drospirenone). A 17 year old woman suddenly collapsed and died after taking the contraceptive for six months. Autopsy showed that she had had a massive pulmonary embolism. No obvious risk factors for thromboembolism, such as smoking, a period of long immobilisation, air flights, or concomitant medication, …
No takes yet. Share an insight, caveat, or question.
Grootheest et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: